Deng L, Wang D, de la Fuente C, Wang L, Li H, Lee C G, Donnelly R, Wade J D, Lambert P, Kashanchi F
Department of Biochemistry and Molecular Biology, UMDNJ-New Jersey Medical School, Newark, New Jersey 07103, USA.
Virology. 2001 Oct 25;289(2):312-26. doi: 10.1006/viro.2001.1129.
HIV-1 Tat is able to form a ternary complex with P/CAF and p300 and increase the affinity for CDK9/P-TEFb CTD kinase complex. Our previous study demonstrated that Tat binds to p300/CBP in the minimal HAT domain (aa 1253-1790) and that the interaction results in a change of conformation on p300/CBP. Here, we show that the Tat-p300 interaction increases the HAT activity of p300 on histone H4 that is associated with nucleosomal DNA and not with free histones. Nucleosomal histone H4 was acetylated on lysines 8, 12, and 16. Acetylation of H4 was inhibited by Lys-coenzyme A (CoA), a selective inhibitor of p300 acetyltransferase activity. Unexpectedly, we also found that Tat could autoacetylate itself, which was specific to lysine residues 41 and 71. Peptides lacking these two lysines could not enhance the HAT activity of p300. Comparison of the sequences of Tat with other HIV-1 clades and HAT containing transcription factors indicated sequence identity in the acetyl-CoA binding motif A, KGXG. Furthermore, when utilizing an in vitro transcription assay, as well as a Tat mutant virus, we found that ectopic expression of only wild-type Tat in the presence of p300, and not a lysine 41 Tat mutant, could activate HIV-1 chromatin DNA, as evidenced by the absence of HIV-1 virion antigen. Therefore, transcription of integrated viral DNA in vivo requires the HAT activity of coactivators that are modulated by Tat to derepress the HIV-1 chromatin structure and aid in activated transcription.
HIV-1反式激活因子(Tat)能够与P/CAF和p300形成三元复合物,并增强对细胞周期蛋白依赖性激酶9/正性转录延伸因子b(CDK9/P-TEFb)羧基末端结构域激酶复合物的亲和力。我们之前的研究表明,Tat在最小的组蛋白乙酰转移酶(HAT)结构域(氨基酸1253 - 1790)中与p300/CBP结合,这种相互作用导致p300/CBP构象发生变化。在此,我们表明Tat与p300的相互作用增强了p300对与核小体DNA相关而非游离组蛋白的组蛋白H4的HAT活性。核小体组蛋白H4在赖氨酸8、12和16位被乙酰化。H4的乙酰化被赖氨酸辅酶A(CoA)抑制,赖氨酸辅酶A是p300乙酰转移酶活性的选择性抑制剂。出乎意料的是,我们还发现Tat能够自身乙酰化,这对赖氨酸残基41和71具有特异性。缺乏这两个赖氨酸的肽不能增强p300的HAT活性。将Tat的序列与其他HIV-1分支以及含HAT的转录因子进行比较,结果表明在乙酰辅酶A结合基序A(KGXG)中存在序列一致性。此外,当利用体外转录测定以及Tat突变病毒时,我们发现仅野生型Tat在p300存在的情况下异位表达,而不是赖氨酸41突变的Tat,能够激活HIV-1染色质DNA,这可通过缺乏HIV-1病毒体抗原得以证明。因此,体内整合病毒DNA的转录需要共激活因子的HAT活性,该活性由Tat调节以解除对HIV-1染色质结构的抑制并有助于激活转录。